Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.3750 (-1.15%) ($38.3750 - $38.3750) on Tue. Sep. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.14% (three month average) | RSI | 40 | Latest Price | $38.3750(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) ICLN(40%) IFRA(24%) IWD(14%) VT(20%) EWI(76%) | Factors Impacting HALO price | HALO will decline at least -1.07% in a week (0% probabilities). XLE(-36%) URA(-68%) XOP(-55%) IDRV(-57%) MCHI(-55%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.07% (StdDev 2.14%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.37(-15.65%) | Resistance Level | $40.09 | 5 Day Moving Average | $39.29(-2.33%) | 10 Day Moving Average | $39.56(-3%) | 20 Day Moving Average | $40.09(-4.28%) | To recent high | -12.9% | To recent low | 12.2% | Market Cap | $5.245b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |